PAR-2 antagonist (Proximagen)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePAR-2 antagonist (Proximagen)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtease-activated receptor-2 antagonists
TargetsProtease-activated receptor-2
Therapy Area/IndicationsDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProximagen Group plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProximagen Group plc
Active IndicationsN/A
Inactive IndicationsDermatitis, Atopic

Other Information

ATC CodeN/A
Related LinksN/A